Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 309231, 7 pages
http://dx.doi.org/10.1155/2012/309231
Research Article

The Effects of Green Tea Consumption on Cardiometabolic Alterations Induced by Experimental Diabetes

1Renal, Cardiovascular and Metabolic Physiopharmacology Laboratory, Health and Biological Science Center, Mackenzie University, 01302-907 São Paulo, Brazil
2School of Arts, Science and Humanities, University of Sao Paulo, Sao Paulo, Brazil

Received 8 September 2011; Revised 22 November 2011; Accepted 1 December 2011

Academic Editor: Mariana Morris

Copyright © 2012 Patricia Fiorino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2010. View at Google Scholar
  2. International Diabetes Federation, “Diabetes and impaired glucose tolerance global burden: prevalence and projections, 2010 and 2030,” International Diabetes Federation, 2011, http://www.diabetesatlas.org/content/diabetes-and-impaired-glucose-tolerance.
  3. J. Peti-Peterdi, J. J. Kang, and I. Toma, “Activation of the renal renin-angiotensin system in diabetes—new concepts,” Nephrology Dialysis Transplantation, vol. 23, no. 10, pp. 3047–3049, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Alvarez-Aguilar, M. L. Enríquez-Ramírez, B. Figueroa-Nuñez et al., “Association between angiotensin-1 converting enzyme gene polymorphism and the metabolic syndrome in a Mexican population,” Experimental and Molecular Medicine, vol. 39, no. 3, pp. 327–334, 2007. View at Google Scholar
  5. S. Boudina and E. D. Abel, “Diabetic cardiomyopathy, causes and effects,” Reviews in Endocrine and Metabolic Disorders, vol. 11, no. 1, pp. 31–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Virtue and A. Vidal-Puig, “Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective,” Biochimica et Biophysica Acta, vol. 1801, no. 3, pp. 338–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. K. Rutter and R. W. Nesto, “Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care,” European Heart Journal, vol. 32, no. 18, pp. 2247–2255, 2011. View at Publisher · View at Google Scholar
  8. P. Kempler, S. Tesfaye, N. Chaturvedi et al., “Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study,” Diabetic Medicine, vol. 19, no. 11, pp. 900–909, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Ewing, I. W. Campbell, and B. F. Clarke, “The natural history of diabetic autonomic neuropathy,” Quarterly Journal of Medicine, vol. 49, no. 193, pp. 95–108, 1980. View at Google Scholar · View at Scopus
  10. V. D. M. A. Farah, K. De Angelis, L. F. Joaquim et al., “Autonomic modulation of arterial pressure and heart rate variability in hypertensive diabetic rats,” Clinics, vol. 62, no. 4, pp. 477–482, 2007. View at Google Scholar · View at Scopus
  11. M. L. Ryan, C. M. Thorson, C. A. Otero, T. Vu, and K. G. Proctor, “Clinical applications of heart rate variability in the triage and assessment of traumatically injured patients,” Anesthesiology Research and Practice, vol. 2011, Article ID 416590, 8 pages, 2011. View at Publisher · View at Google Scholar
  12. A. Malliani, M. Pagani, F. Lombardi, and S. Cerutti, “Cardiovascular neural regulation explored in the frequency domain,” Circulation, vol. 84, no. 2, pp. 482–492, 1991. View at Google Scholar · View at Scopus
  13. G. Baselli, S. Cerutti, and S. Civardi, “Spectral and cross-spectral analysis of heart rate and arterial blood pressure variability signals,” Computers and Biomedical Research, vol. 19, no. 6, pp. 520–534, 1986. View at Google Scholar
  14. M. Pagani, G. Malfatto, S. Pierini et al., “Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy,” Journal of the Autonomic Nervous System, vol. 23, no. 2, pp. 143–153, 1988. View at Google Scholar · View at Scopus
  15. L. F. Joaquim, V. M. Farah, I. Bernatova, R. Fazan, R. Grubbs, and M. Morris, “Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 287, no. 1, pp. H251–H257, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Mostarda, B. Rodrigues, M. Vane et al., “Autonomic impairment after myocardial infarction: role in cardiac remodelling and mortality,” Clinical and Experimental Pharmacology and Physiology, vol. 37, no. 4, pp. 447–452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. TASK Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, “Heart rate variability,” European Heart Journal, vol. 17, no. 3, pp. 354–381, 1996. View at Google Scholar
  18. V. Farah, K. M. Elased, Y. Chen et al., “Nocturnal hypertension in mice consuming a high fructose diet,” Autonomic Neuroscience, vol. 130, no. 1-2, pp. 41–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Vita, G. Bellinghieri, A. Trusso et al., “Uremic autonomic neuropathy studied by spectral analysis of heart rate,” Kidney International, vol. 56, no. 1, pp. 232–237, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Galinier, A. Pathak, J. Fourcade et al., “Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure,” European Heart Journal, vol. 21, no. 6, pp. 475–482, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. M. T. La Rovere, G. D. Pinna, R. Maestri et al., “Short-term heart rate variability strongly predicts sudden cadiac death in chronic heart failure patients,” Circulation, vol. 107, no. 4, pp. 565–570, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Parati, G. Pomidossi, and F. Albini, “Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension,” Journal of Hypertension, vol. 5, no. 1, pp. 93–98, 1987. View at Google Scholar · View at Scopus
  23. S. Wolfram, “Effects of green tea and EGCG on cardiovascular and metabolic health,” Journal of the American College of Nutrition, vol. 26, no. 4, pp. 373S–388S, 2007. View at Google Scholar · View at Scopus
  24. H. Arisawa, K. Fukui, and H. Masunaga, “General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome—3rd communication: effects on respiratory and cardiovascular systems,” Arzneimittel-Forschung/Drug Research, vol. 52, no. 3, pp. 162–167, 2002. View at Google Scholar · View at Scopus
  25. H. Tsuneki, M. Ishizuka, M. Terasawa, J. B. Wu, T. Sasaoka, and I. Kimura, “Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans,” BMC Pharmacology, vol. 4, article 18, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Kawaguchi, T. Matsumoto, and Y. Kumazawa, “Effects of antioxidant polyphenols on TNF-alpha-related diseases,” Current Topics in Medicinal Chemistry, vol. 11, no. 14, pp. 1767–1779, 2011. View at Publisher · View at Google Scholar
  27. P. V. A. Babu, K. E. Sabitha, and C. S. Shyamaladevi, “Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats,” Chemico-Biological Interactions, vol. 162, no. 2, pp. 114–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. P. V. A. Babu, K. E. Sabitha, P. Srinivasan, and C. S. Shyamaladevi, “Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats,” Pharmacological Research, vol. 55, no. 5, pp. 433–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. W. M. Renno, S. Abdeen, M. Alkhalaf, and S. Asfar, “Effect of green tea on kidney tubules of diabetic rats,” British Journal of Nutrition, vol. 100, no. 3, pp. 652–659, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Juśkiewicz, Z. Zduńczyk, A. Jurgoński, Ł. Brzuzan, I. Godycka-Kłos, and E. Zary-Sikorska, “Extract of green tea leaves partially attenuates streptozotocin-induced changes in antioxidant status and gastrointestinal functioning in rats,” Nutrition Research, vol. 28, no. 5, pp. 343–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. V. J. D. D. Silva, T. Gnecchi-Ruscone, B. Lavelli et al., “Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats,” American Journal of Physiology, vol. 283, no. 2, pp. R543–R548, 2002. View at Google Scholar · View at Scopus
  32. V. M. Farah, K. M. Elased, and M. Morris, “Genetic and dietary interactions: angiotensin AT1a receptors and the cardiovascular and metabolic responses to a fructose diet,” American Journal of Physiology Heart and Circulation Physiology, vol. 293, no. 2, pp. H1083–H1089, 2007. View at Google Scholar
  33. A. Junod, A. E. Lambert, W. Stauffacher, and A. E. Renold, “Diabetogenic action of streptozotocin: relationship of dose to metabolic response,” Journal of Clinical Investigation, vol. 48, no. 11, pp. 2129–2139, 1969. View at Google Scholar · View at Scopus
  34. K. C. Tomlinson, S. M. Gardiner, R. A. Hebden, and T. Bennett, “Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system,” Pharmacological Reviews, vol. 44, no. 1, pp. 103–150, 1992. View at Google Scholar · View at Scopus
  35. K. De Angelis, M. C. Irigoyen, and M. Morris, “Diabetes and cardiovascular autonomic dysfunction: application of animal models,” Autonomic Neuroscience, vol. 145, no. 1-2, pp. 3–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. M. Rains, S. Agarwal, and K. C. Maki, “Antiobesity effects of green tea catechins: a mechanistic review,” Journal of Nutritional Biochemistry, vol. 22, no. 1, pp. 1–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. S. Westerterp-Plantenga, “Green tea catechins, caffeine and body-weight regulation,” Physiology and Behavior, vol. 100, no. 1, pp. 42–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Hosoda, M. F. Wang, M. L. Liao et al., “Antihyperglycemic effect of oolong tea in type 2 diabetes,” Diabetes Care, vol. 26, no. 6, pp. 1714–1718, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Y. Wu, C. C. Juan, L. T. Ho, Y. P. Hsu, and L. S. Hwang, “Effect of green tea supplementation on insulin sensitivity in sprague-dawley rats,” Journal of Agricultural and Food Chemistry, vol. 52, no. 3, pp. 643–648, 2004. View at Google Scholar · View at Scopus
  40. P. D. B. Ribaldo, D. S. Souza, S. K. Biswas, K. Block, J. M. L. De Faria, and J. B. L. De Faria, “Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats,” Journal of Nutrition, vol. 139, no. 1, pp. 96–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Dall'Ago, T. G. Fernandes, U. F. Machado, A. A. Belló, and M. C. Irigoyen, “Baroreflex and chemoreflex dysfunction in streptozotocin-diabetic rats,” Brazilian Journal of Medical and Biological Research, vol. 30, no. 1, pp. 119–124, 1997. View at Google Scholar · View at Scopus
  42. A. Boku, M. Sugimura, Y. Morimoto, H. Hanamoto, and H. Niwa, “Hemodynamic and autonomic response to acute hemorrhage in streptozotocin-induced diabetic rats,” Cardiovascular Diabetology, vol. 9, article 78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. H. M. El-Bassossy, A. Fahmy, and D. Badawy, “Cinnamaldehyde protects from the hypertension associated with diabetes,” Food and Chemical Toxicology, vol. 49, no. 11, pp. 3007–3012, 2011. View at Publisher · View at Google Scholar
  44. J. Zúrová-Nedelčevová, J. Navarová, K. Drábiková et al., “Participation of reactive oxygen species in diabetes- induced endothelial dysfunction,” Neuroendocrinology Letters, vol. 27, no. 2, supplement, pp. 168–171, 2006. View at Google Scholar
  45. O. O. Erejuwa, S. A. Sulaiman, M. S.A. Wahab, K. N.S. Sirajudeen, and M. S.M. Salleh, “Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic wistar-kyoto rats and spontaneously hypertensive rats: effects of antioxidant (Honey) treatment,” International Journal of Molecular Sciences, vol. 12, no. 3, pp. 1888–1907, 2011. View at Publisher · View at Google Scholar
  46. R. L. Rodgers, “Depressor effect of diabetes in the spontaneously hypertensive rat: associated changes in heart performance,” Canadian Journal of Physiology and Pharmacology, vol. 64, no. 9, pp. 1177–1184, 1986. View at Google Scholar · View at Scopus
  47. D. Giugliano, A. Ceriello, and G. Paolisso, “Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?” Metabolism, vol. 44, no. 3, pp. 363–368, 1995. View at Google Scholar · View at Scopus
  48. D. Giugliano, A. Ceriello, and G. Paolisso, “Oxidative stress and diabetic vascular complications,” Diabetes Care, vol. 19, no. 3, pp. 257–267, 1996. View at Google Scholar · View at Scopus
  49. F. Bellavere, I. Balzani, G. De Masi et al., “Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy,” Diabetes, vol. 41, no. 5, pp. 633–640, 1992. View at Google Scholar · View at Scopus
  50. J. V. Higdon and B. Frei, “Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions,” Critical Reviews in Food Science and Nutrition, vol. 43, no. 1, pp. 89–143, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Yokozawa, T. Nakagawa, and K. Kitani, “Antioxidative activity of green tea polyphenol in cholesterol-fed rats,” Journal of Agricultural and Food Chemistry, vol. 50, no. 12, pp. 3549–3552, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Skrzydlewska, J. Ostrowska, R. Farbiszewski, and K. Michalak, “Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain,” Phytomedicine, vol. 9, no. 3, pp. 232–238, 2002. View at Google Scholar · View at Scopus
  53. T. Nakagawa and T. Yokozawa, “Direct scavenging of nitric oxide and superoxide by green tea,” Food and Chemical Toxicology, vol. 40, no. 12, pp. 1745–1750, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Manzella, M. Barbieri, E. Ragno, and G. Paolisso, “Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes,” American Journal of Clinical Nutrition, vol. 73, no. 6, pp. 1052–1057, 2001. View at Google Scholar · View at Scopus